期刊文献+

Ⅰ~Ⅲ期根治术后左右半结肠癌预后差异分析 被引量:9

Prognostic factors of patients with stagesⅠ-Ⅲ left-sided versus right-sided colon cancer receiving radical surgery
原文传递
导出
摘要 目的:探讨Ⅰ~Ⅲ期根治术后左半结肠癌(left-sided colon cancer,LCC)与右半结肠癌(right-sided colon cancer,RCC)患者预后的影响因素。方法 :回顾性分析2008年2月—2012年2月在安徽医科大学附属省立医院接受根治术的332例Ⅰ~Ⅲ期结直肠癌(colorectal cancer,CRC)患者的临床资料。应用χ2检验分析原发肿瘤位置与临床病理特征之间的相关性;采用Kaplan-Meier法绘制生存曲线,log-rank法和COX回归模型分别进行CRC患者预后的单因素和多因素分析。结果 :所有患者的5年总生存率为69.9%。LCC与RCC患者5年总生存率的差异有统计学意义(72.6%vs 66.9%,P=0.020)。其中,Ⅲ期LCC患者的5年总生存率高于RCC患者(62.5%vs 52.2%,P=0.018),但Ⅰ、Ⅱ期LCC患者与RCC患者5年总生存率的差异均无统计学意义(P>0.05)。LCC与RCC患者的肿瘤T分期、组织学分类、分化程度、肿瘤最大直径以及血红蛋白、血清白蛋白、血浆纤维蛋白原和血清癌胚抗原水平的差异有统计学意义(P值均<0.05)。单因素分析结果显示,肿瘤部位、T分期、N分期、组织学分类、分化程度、肿瘤最大直径以及血红蛋白、血清白蛋白、血浆纤维蛋白原和血清癌胚抗原水平与5年总生存率有关(P值均<0.05)。多因素分析结果显示,肿瘤N分期、组织学分类、分化程度以及血红蛋白、血清白蛋白、血浆纤维蛋白原和血清癌胚抗原水平是CRC的独立预后因素(P值均<0.05)。结论 :对于Ⅰ~Ⅲ期根治术后CRC患者,肿瘤N分期较高、黏液腺癌/印戒细胞癌、低分化癌、贫血、低白蛋白血症、血浆纤维蛋白原≥4 g/L、血清癌胚抗原≥10 ng/m L提示预后不良。LCC与RCC的的临床病理特征和预后存在差异,但原发肿瘤位置不是独立的预后因素。 Objective: To investigate the prognostic factors of patients with stages Ⅰ-Ⅲ left-sided colon cancer(LCC) versus right-sided colon cancer(RCC) receiving radical surgery.Methods: A retrospective analysis of clinical data from 332 patients with stages Ⅰ-Ⅲ colorectal cancer(CRC) who underwent radical surgery in Anhui Provincial Hospital, Anhui Medical University between February 2008 and February 2012 was conducted. The differences in clinicopathological characteristics by tumor location(RCC vs LCC) were examined by using χ2 test. The comparisons of overall 5-year survival rate between RCC and LCC within each stage and for all stages were done by using Kaplan-Meier method. The univariate analysis of prognosis was performed by using log-rank test, and the multivariate analysis was performed by using COX regression model.Results: The overall 5-year survival rate of all patients was 69.9%. The LCC patients had significantly higher overall 5-year survival rate than RCC patients(72.6% vs 66.9%, P = 0.020). The stage Ⅲ LCC patients had significantly higher overall 5-year survival rate than the stage Ⅲ RCC patients(62.5% vs 52.2%,P = 0.018), but no significant difference in overall 5-year survival rate was found between stage Ⅰ or Ⅱ RCC and LCC patients(P〉0.05). There were significant differences in T stage, histologic type, degree of differentiation, tumor size, hemoglobin, albumin, fibrinogen and carcinoembryonic antigen(CEA) between RCC and LCC patients(all P 〈0.05). The univariate analysis showed that tumor location, T stage, N stage, histologic type, degree of differentiation, tumor size, hemoglobin, albumin, fibrinogen and CEA were significantly correlated with overall 5-year survival rate of CRC patients(all P〈 0.05). Multivatiate analysis showed that N stage, histologic type, degree of differentiation, hemoglobin, albumin, fibrinogen and CEA were independent prognostic factors of CRC(all P〈 0.05).Conclusion: For patients with stages Ⅰ-Ⅲ CRC treated with radical surgery, the factors of higher tumor N stage, mucinous adenocarcinoma/signet ring cell carcinoma, poorly differentiated carcinoma, anemia, hypoproteinemia, fibrinogen level more than 4 g/L and CEA level more than 10 ng/m L indicate a poor prognosis. The significant differences in clinicopathological characteristics and prognosis are found between RCC and LCC, but the tumor location is not an independent prognostic factor.
出处 《肿瘤》 CAS CSCD 北大核心 2017年第9期981-988,共8页 Tumor
关键词 结直肠肿瘤 左半结肠癌 右半结肠癌 临床病理特征 预后 Colorectal neoplasms Left-sided colon cancer Right-sided colon cancer Clinicopathological characteristics Prognosis
  • 相关文献

参考文献1

二级参考文献14

  • 1Xu JM. Difference of colon cancer and rectal cancer-from the view of an oncological physician[ J ]. Chin J Oncol, 2010, 32 (5) :321- 323. DOIi 10.3760/cma.j.issn. 0253-3766. 2010.05.001.
  • 2Masoomi H, Buchberg B, Dang P, et al. Outcomes of right vs.left colectomy for colon cancer [ J]. J Gastrointest Surg, 2011, 15 ( 11 ) :2023-2028. DOI : 10.1007/s 11605-011-1655-y.
  • 3Iacopetta B. Are there two sides to colorectal cancer? [ J]. Int J Cancer, 2002, 101(5):403-408. DOI: 10.1002/ijc.10635.
  • 4Moritani K, Hasegawa H, Okabayashi K, et al. Difference in the recurrence rate between right-and left-sided colon cancer: a 17- year experience at a single institution [J]. Surg Today, 2014,44 (9) : 1685-1691. DOI: 10.1007/s00595-013-0748 -5.
  • 5Meguid RA, Slidell MB, Wolfgang CL, et al. Is there a difference in survival between right-versus left-sided colon cancers? [ J ]. Ann Surg Oncol, 2008, 15 (9): 2388-2394. DOI: 10. 1245/ s10434-008-0015-y.
  • 6Benedix F, Kube R, Meyer F, et al. Comparison of 17,641 patients with right-and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival [ J ]. Dis Colon Rectum, 2010, 53( 1 ) :57-64. DOI : lO.1007/DCR.Ob013e3181c703a4.
  • 7Weiss JM, Schumacher J, Allen GO, et al. Adjuvant chemotherapy for stage Ⅱ right-sided and left-sided colon cancer: analysis of SEER- medicare data I J ]. Ann Surg Oncol, 2014,21 (6) : 1781-1791. DOI: 10.1245/s10434-014-3631-8.
  • 8Price TJ, Beeke C, Ullah S, et al. Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease? [ J ]. Cancer, 2015,121 (6) :830-835. DOI : 10.1002/cncr.29129.
  • 9Klingbiel D, Saridaki Z, Roth AD, et al. Prognosis of stage Ⅱ and Ⅲ colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status : results of the PETACC-3 trial [ J ]. Ann Oncol, 2015,26(1) : 126-132. DOI : 10.1093/annonc/mdu499.
  • 10Andreou A, Kopetz S, Maru DM, et al. Adjuvant chemotherapy with FOLFOX for primary coloroctal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases [ J 1. Ann Surg, 2012,256(4) :642-650. DOI : 10.1097/SLA.0b013e31826b4dee.

共引文献19

同被引文献74

引证文献9

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部